Geometry.Net - Health_Conditions: Polymyositis


Home - Health_Conditions - Polymyositis

e99.com Bookstore

Images

Newsgroups

21-40 of 98 Back | 1 | 2 | 3 | 4 | 5 | Next 20

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Polymyositis: more books (23)

Diseases Volume 7 Polymyositis - Spasm

Dermatomyositis & polymyositis (MSS' series on chronic diseases of man)

Acute dermatomyositis-polymyositis and malignancy (Seminars in arthritis and rheumatism) by John Harold Talbott, 1977

Subacute progressive polymyositis by George W Jacoby, 1888

Dermatomyositis: Advances in Recognition, Understanding and Management by Lyubomir A. Dourmishev, Assen Lyubenov Dourmishev, 2009-05-11

Molecular and Cell Biology of Autoantibodies and Autoimmunity. Abstracts: First International Workshop, July 27-29, 1989, Heidelberg (Sitzungsberichte ... Wissenschaften / Sitzungsber.Heidelberg 89)

The Inflammatory Myopathies

...Broken Glass and All: An Inspiring Journey of Hope and Healing by Al Squitieri Sr., 2001-02-19

Coping with a Myositis Disease

lists with details

Polymyositis
polymyositis is an inflammatory muscle disease that causes varyingdegrees of decreased muscle power. Subscribe now . polymyositis.
http://healthlink.mcw.edu/article/921449523.html

Extractions: Subscribe now >> Polymyositis is an inflammatory muscle disease that causes varying degrees of decreased muscle power. The disease has a gradual onset and generally begins in the second decade of life. Polymyositis rarely affects persons under the age of 18. The most common symptom is muscle weakness, usually affecting those muscles that are closest to the trunk of the body (proximal). Eventually, patients have difficulty rising from a sitting position, climbing stairs, lifting objects, or reaching overhead. In some cases, distal muscles (those not close to the trunk of the body) may also be affected later in the course of the disease. Trouble with swallowing (dysphagia) may occur. Occasionally, the muscles ache and are tender to touch. Patients may also feel fatigue and discomfort and have weight loss or a low-grade fever. Treatment for polymyositis generally consists of a steroid drug called prednisone. For patients in whom prednisone is not effective, immunosuppressants such as azathioprine and methotrexate may be prescribed. Physical therapy is usually recommended to preserve muscle function and avoid muscle atrophy.
Inflammatory Myopathy
polymyositis. polymyositis Clinical features Muscle weakness Proximal Distal;Symmetric; Selective regions of weakness Dysphagia; Posterior neck; Quadriceps.
http://www.neuro.wustl.edu/neuromuscular/antibody/infmyop.htm
POLYMYOSITIS
polymyositis. 1) Boyd,AS, Neldner,KH Therapeutic options in dermatomyositis/polymyositis.Internat J Dermatol 33240250,1994. Cyclosporine. Neoral.
http://www.neuro.wustl.edu/neuromedical_treatment/polymyos.html

Extractions: POLYMYOSITIS Treatment is long term immunosuppression, in the largest number of reported patients with PO corticosteroids, in the event of steroid toxicity supplemented at lower steroid doses with azathioprine or, in a few cases, with cyclosporine. Supplementation with methotrexate has also been reported but there are many toxicities to be considered. IV immunoglobulin has been used successfully in a small number of patients, alone or with other immunosuppressants.....the major difficulty is cost, not toxicity. A satisfactory response to immunosuppressants may be expected in two-thirds of the patients, or more. The only favorable experience in inclusion body myositis has been reported, in a few cases, with IV immunoglobulin. Azathioprine Imuran. Tab 50 mg. Begin with 50 mg od increased by 50 mg increments at weekly intervals until a dose of 2-3 mg/kg od is reached. The daily amount may be given in a single dose or in divided doses bid. Maintainance dose thereafter is determined by clinical response and WBC....in regard to the latter, 3-4 K/cmm is the value desired. The response, if it occurs, is typically delayed, the time from onset of treatment varying from 3 to 12 months. Time to maximal improvement varies from 1 to 2 years. Judgement regarding response should not be made before 1 year of treatment has been completed. The drug may be used alone or with a corticosteroid. Studies report 60-70% success. Until a stable maintainance dose has been reached liver chemistries and a CBC should be done weekly, then every 2 months. Hepatotoxicity is less than with methotrexate. For gastric distress sucralfate (Carafate) may be prescribed. 10% of patients develope a hypersensitivity reaction with fever, abdominal symptomatology, malaise and, sometimes, a rash.....if so, treatment with this agent is terminated at once without gradual reduction and not resumed.
Polymyositis
polymyositis, See Also Dermatomyositis. Types Type 1 Primary Idiopathicpolymyositis (33%); Type 2 Primary Idiopathic Dermatomyositis (25%);
http://www.fpnotebook.com/RHE19.htm

Extractions: Home About Links Index ... Editor's Choice Paid Advertisement (click above). Please see the privacy statement Rheumatology Diffuse Assorted Pages Amyloidosis Antiphospholipid Antibody Syndrome Systemic Lupus Erythematosus Polymyalgia Rheumatica ... Medication Causes of Myositis Polymyositis Book Home Page Cardiovascular Medicine Dental Dermatology Emergency Medicine Endocrinology Gastroenterology General Medicine Geriatric Medicine Gynecology Hematology and Oncology HIV Infectious Disease Jokes Laboratory Neonatology Nephrology Neurology Obstetrics Ophthalmology Orthopedics Otolaryngology Pediatrics Pharmacology Prevention Psychiatry Pulmonology Radiology Rheumatology Sports Medicine Surgery Urology Chapter Rheumatology Index Bone Cardiovascular Medicine Diffuse Examination Infectious Disease Intra-Articular Disorders Laboratory General Marfans Myofascial Neurology Osteoarthritis Pain Pediatrics Pharmacology Procedure Radiology RA Spondylitis Symptom Evaluation Page Diffuse Index Amyloidosis Behcets Syndrome Lupus Anticoagulant Lupus Systemic Polymyalgia Rheumatica Polymyositis Background Polymyositis DDx Polymyositis Evaluation Polymyositis Management Polymyositis Types Idiopathic Scleroderma Sjogren's See Also Dermatomyositis Types Type 1: Primary Idiopathic Polymyositis Type 2: Primary Idiopathic Dermatomyositis Type 3: Neoplasia related Type 4: Childhood disease with Vasculitis Type 5: Collagen Vascular disease related Type 6: Miscellaneous (Inclusion body
Polymyositis Evaluation
polymyositis Evaluation Dermatomyositis Evaluation. Signal Recognition Particle (SRP)Seen in 5% of polymyositis; Associated in severe, acuteonset polymyositis
http://www.fpnotebook.com/RHE21.htm

Extractions: Home About Links Index ... Editor's Choice Paid Advertisement (click above). Please see the privacy statement Rheumatology Diffuse Assorted Pages Amyloidosis Antiphospholipid Antibody Syndrome Systemic Lupus Erythematosus Polymyalgia Rheumatica ... Medication Causes of Myositis Polymyositis Evaluation Dermatomyositis Evaluation Book Home Page Cardiovascular Medicine Dental Dermatology Emergency Medicine Endocrinology Gastroenterology General Medicine Geriatric Medicine Gynecology Hematology and Oncology HIV Infectious Disease Jokes Laboratory Neonatology Nephrology Neurology Obstetrics Ophthalmology Orthopedics Otolaryngology Pediatrics Pharmacology Prevention Psychiatry Pulmonology Radiology Rheumatology Sports Medicine Surgery Urology Chapter Rheumatology Index Bone Cardiovascular Medicine Diffuse Examination Infectious Disease Intra-Articular Disorders Laboratory General Marfans Myofascial Neurology Osteoarthritis Pain Pediatrics Pharmacology Procedure Radiology RA Spondylitis Symptom Evaluation Page Diffuse Index Amyloidosis Behcets Syndrome Lupus Anticoagulant Lupus Systemic Polymyalgia Rheumatica Polymyositis Background Polymyositis DDx Polymyositis Evaluation Polymyositis Management Polymyositis Types Idiopathic Scleroderma Sjogren's See Also Polymyositis Dermatomyositis Labs: Muscle Enzymes Serum Aldolase Alanine Aminotransferase (ALT) Aspartate Aminotransferase (AST) Lactate Dehydrogenase (LDH) Creatine Phosphokinase (CPK) Carbonic Anhydrase (isoenzyme III) Limited availability Lab: General Erythrocyte Sedimentation Rate (ESR) Increased in 50% of cases
Myositis - About Myositis
inflammation). Myositis refers to several different illnesses, includingpolymyositis, dermatomyositis, and inclusion body myositis.
http://www.orthop.washington.edu/arthritis/types/myositis/01

Extractions: Last updated May 1, 2002 About myositis Myositis is the term for illnesses that involve chronic muscle inflammation ("myo" means muscle and "itis" means inflammation). "Myositis" refers to several different illnesses, including polymyositis, dermatomyositis, and inclusion body myositis. All forms of myositis involve chronic, or persistent, muscle inflammation. This muscle inflammation almost always results in weakness, and less often in heat, swelling, and pain of the muscles. Myositis can affect many parts of the body. Sometimes the joints, heart, lungs, intestines, and skin can become inflamed. Some forms of myositis, like dermatomyositis ("dermato" refers to the skin), result in particular rashes over the knuckles, around the eyes, or sometimes in other parts of the body. Other forms of myositis occur in children. Some forms are seen with other connective tissues diseases, like lupus or rheumatoid arthritis . Still other forms may occur in people with tumors. Rarely, myositis can occur in a single part of the body, such as one arm, one leg, or just the muscles that move the eye.
1Up Health > Polymyositis (adult) > Causes, Incidence, And Risk Factors Of Polym
Comprehesive information on polymyositis (adult) . 1Up Health Diseases Conditions polymyositis (adult) Causes, Incidence, and Risk Factors.
http://www.1uphealth.com/health/polymyositis_adult_info.html

Extractions: 1Up Health Polymyositis (adult) Alternative Medicine Clinical Trials ... Health Topics A-Z Search 1Up Health Polymyositis (adult) Information Polymyositis (adult) Causes, Incidence, and Risk Factors Definition : A systemic connective tissue disease, which is characterized by inflammation and degeneration of the muscles. The cause of this disorder is unknown. It is thought that an autoimmune reaction or a viral infection of the skeletal muscle may cause the disease. It can affect people at any age, but most commonly occurs in those between 50 to 70 years old, or in children between 5 to 15 years old. It affects women twice as often as men. Muscle weakness may appear suddenly or occur slowly over weeks or months. There may be difficulty with raising the arms over the head, rising from a sitting position, or climbing stairs. The voice may be affected through weakness of the throat muscles. Joint pain inflammation of the heart , and pulmonary (lung) disease may occur. A similar condition, called dermatomyositis , is evident when a dusky, red rash appears over the face, neck, shoulders, upper chest, and back. A
Polymyositis Diary
polymyositis Adam a diary of my PM experiences (Sounds like a badchildren's book, but it's the only title I could think of.)
http://home.sprintmail.com/~edam/polym.html
Page 34 Home
polymyositis and Dermatomyositis. polymyositis and dermatomyositis(PMDM) are autoimmune neuromuscular diseases. They are sometimes
http://www.aarda.org/page34.html

Extractions: Polymyositis and Dermatomyositis Polymyositis and dermatomyositis (PM-DM) are autoimmune neuromuscular diseases. They are sometimes referred to as connective tissue diseases. Polymyositis and dermatomyositis can occur in all ages and both sexes, although they are more common in women; and childhood disease is differentiated from the adult type. A recent study (Nurse Health Study 1976-1990) found that the incidence of polymyositis affects approximately 120 women per million. The clinical hallmark of these diseases is proximal limb and neck weakness, sometimes associated with muscle pain. A skin rash on the face and upper chest area is present in dermatomyositis, distinguishing it from polymyositis. There is usually an elevated blood level of CPK. Autoimmune factors are felt to be important, because autoantibodies are present in most patients. Some of the antibodies found in myositis are anti-Jo-1, anti-PL-12, anti-EJ, anti-OJ, anti-Mi-2, anti-MAS, anti-Fer, and anti-SRP. For more information on polymyositis and dermatomyositis or other autoimmune disorders, please click on the request information icon below.
Medic-Planet Polymyositis
polymyositis Advertisement See also Muscles, Back to the Index page CauseDoctors do not know what initiates polymyositis or dermatomyositis .
http://www.medic-planet.com/MP_article/internal_reference/Polymyositis
Medic-Planet Polymyositis
polymyositis Advertisement See also Muscles, Back to the Index page CauseDoctors do not know what initiates polymyositis or dermatomyositis .
http://www.medic-planet.com/MP_article/internal_reference/polymyositis
Polymyositis
MAIN SEARCH INDEX polymyositis. Definition. polymyositis is an inflammatorymuscle disease causing weakness and pain. Dermatomyositis
http://www.hendrickhealth.org/healthy/001093.htm

Extractions: Resources Polymyositis is an inflammatory muscle disease causing weakness and pain . Dermatomyositis is identical to polymyositis with the addition of a characteristic skin rash. Polymyositis (PM) is an inflammatory disorder in which muscle tissue becomes inflamed and deteriorates, causing weakness and pain. It is one of several types of inflammatory muscle disease, or myopathy. Others include dermatomyositis (DM) and inclusion body myositis. All three types are progressive conditions, usually beginning in adulthood. A fourth type, juvenile dermatomyositis, occurs in children. Although PM and DM can occur at any age, 60% of cases appear between the ages of 30 and 60. Females are affected twice as often as males. Causes The cause of PM and DM is not known, but it is suspected that a variety of factors may play a role in the development of these diseases. PM and DM may be autoimmune diseases, caused by the immune system's attack on the body's own tissue. The reason for this attack is unknown, although some researchers believe that a combination of immune system susceptibility and an environmental trigger may explain at least some cases. Known environmental agents associated with PM and DM include infectious agents such as Toxoplasma Borrella Lyme disease bacterium), and coxsackievirus. Most cases, however, have no obvious triggers (direct causative agents). There may also be a genetic component in the development of PM and DM.
Polymyositis
Translate this page polymyositis. Antworten Ihre Antwort Forum www.medizin-ring.de Suchedringend Kontakt zu Menschen denen die Krankheit polymyositis etwas sagt.
http://www.medizin-ring.de/forum/messages/23.html

Extractions: Re: polymyositis Elvira Re: polymyositis Sven Re: polymyositis Sven Re: polymyositis Andrea Re: polymyositis Sven Re: polymyositis ute Re: polymyositis Rita Fischhöfer Re: polymyositis Barbara Pilawa Re: polymyositis Anke Re: polymyositis Yvi Re: polymyositis Barcal Silvia Re: polymyositis anja Re: polymyositis Alexa
Re: Polymyositis
Translate this page Re polymyositis. Antworten Ihre Antwort Forum www.medizin-ring.de Antwortauf polymyositis von billygirl am 21 April, 2002 um 122639 Hallöle,.
http://www.medizin-ring.de/forum/messages/55.html

Extractions: Antworten Ihre Antwort Forum www.medizin-ring.de Abgeschickt von Rita Fischhöfer am 06 Januar, 2003 um 20:07:17 Antwort auf: polymyositis von billygirl am 21 April, 2002 um 12:26:39: Hallöle, ich leide zwar nicht selber an dieser Krankheit, jedoch ist meine Freundin seit ca. 4 Jahren davon betroffen. Da sie auf der Suche nach einer Selbsthilfegruppe ist, kann ich auf diesem Weg ja vielleicht ne Info bekommen. Gruß Rita
Juvenile Dermatomyositis And Polymyositis
Juvenile Dermatomyositis and polymyositis A Followup Study of Long-termSequelae. CRAIG H. COLLISON, SARA H. SINAL, MD, JOSEPH
http://www.sma.org/smj1998/jansmj98/3text.htm

Extractions: Juvenile Dermatomyositis and Polymyositis A Follow-up Study of Long-term Sequelae CRAIG H. COLLISON, SARA H. SINAL, MD, JOSEPH L. JORIZZO, MD, FRANCIS O. WALKER, MD, JOHNNY U. V. MONU, MD, and JANE SNYDER, PT, Winston-Salem, NC Abstract Background. Juvenile dermatomyositis/polymyositis (JDMS/PM) are childhood inflammatory myopathies that normally affect children between 2 and 15 years of age. The disease is manifested as severe proximal muscle weakness and, in JDMS, as a characteristic cutaneous eruption. It is difficult to predict the course of the disease. This study is aimed at objectively assessing the long-term morbidity of dermatomyositis/polymyositis in children. Methods. Twelve cases of JDMS/PM identified through chart review were evaluated by physical and dermatologic examination, muscle testing, ultrasonography, and magnetic resonance imaging (MRI). Conclusions. Multiple physical and dermatologic sequelae are commonly present in patients with JDMS/PM on long-term follow-up, but these do not preclude a productive life. Ultrasonography and MRI provide additional noninvasive means of analysis, but because of the current high cost, MRI is not routinely recommended. JUVENILE dermatomyositis/polymyositis (JDMS/PM) is a childhood form of inflammatory myopathy usually affecting children from 2 to 15 years of age. It is manifested by severe proximal muscle weakness and, in JDMS, by a characteristic cutaneous eruption. Other less common signs and symptoms include dysphagia, cardiac conduction abnormalities, and restrictive ventilatory dyspnea.1-3 Polymyositis (PM) has the same features as JDMS but without the cutaneous involvement.
Bronchiolitis Obliterans Organizing Pneumonia As The First Manifestation Of Poly
Bronchiolitis Obliterans Organizing Pneumonia as the First Manifestation of polymyositis. Quadricepsfemoris muscle biopsy was compatible with polymyositis.
http://www.sma.org/smj/97feb13.htm

Extractions: ABSTRACT: Bronchiolitis obliterans organizing pneumonia (BOOP) preceding polymyositis is rare. In this report, a 51-year-old patient with fever, nonproductive cough, and dyspnea had bilateral basal interstitial infiltrates on chest roentgenogram. Open lung biopsy was consistent with BOOP. Prednisone therapy led to improvement, but 8 weeks later, fever, cough, and weakness of the arms and legs developed because the patient had not been compliant with the prednisone regimen. The creatine kinase (CK), the macrophage inflammatory protein (MIP-1), and the tumor necrosis factor (TNF-a a levels declined significantly. This is only the second reported case of BOOP preceding polymyositis. Patients with idiopathic BOOP should have follow-up for the possible development of connective tissue disorders including polymyositis. THE PULMONARY MANIFESTATIONS of polymyositis include usual interstitial pneumonitis, bronchiolitis obliterans, diffuse alveolar damage, pulmonary capillaritis, and bronchiolitis obliterans organizing pneumonia (BOOP).1,2 In 1985, Epler et al3 described BOOP as a distinct entity. BOOP presents with fever associated with cough and dyspnea. Pathologically, although there is a cellular interstitial pneumonitis, the organizing pneumonia consists of proliferating fibroblasts that lay down mucopolysaccharides and young connective tissue.4 The entity must be distinguished from bronchiolitis obliterans, which affects only the distal bronchioles, and from organizing pneumonitis and organizing diffuse alveolar damage, which affect only the alveoli.4 BOOP preceding or coexisting with polymyositis is rare. We report the second case of BOOP preceding polymyositis5 and show that cytokines play a role in the pathogenesis of BOOP associated with polymyositis.
Florida State University College Of Medicine Digital Library
Dermatomyositis and polymyositis Patient/Family Resources. Miscellaneous Dermatomyositisand polymyositis Patients/Family Resources Healthfinder Homepage
http://fsumed-dl.slis.ua.edu/patientinfo/rheumatology/autoimmune/dermatomyositis

Extractions: Patient/Family Resources by Topic: Musculoskeletal Disorders Dermatomyositis and Polymyositis Patient/Family Resources Pediatrics Spanish Miscellaneous See also: American College of Rheumatology: Homepage American Autoimmune Related Diseases Association: Homepage American Pain Foundation: Homepage MEDLINE plus Medical Encyclopedia: Table of contents InteliHealth Disease and Condition Guide Table of contents Merck Manual Home Edition Table of contents Chapter 51. Disorders of Joints and Connective Tissue:
Florida State University College Of Medicine Digital Library
Dermatomyositis and polymyositis Clinical Resources. Miscellaneous Dermatomyositisand polymyositis Clinical Resources HealthWeb Homepage
http://fsumed-dl.slis.ua.edu/clinical/rheumatology/autoimmune/dermatomyositis.ht

Extractions: Clinical Resources by Topic: Musculoskeletal Disorders Dermatomyositis and Polymyositis Clinical Resources Emergency Pediatrics Geriatrics Atlases ... Miscellaneous Resources See also: Chapter 58: Immunologically Mediated Skin Diseases: Table of contents Chapter 275: Glomerulopathies Associated with Multisystem Diseases: Table of contents Chapter 259: Interstitial Lung Diseases: Table of contents Initial Evaluation: Access document Introduction: Access document History:
POLYMYOSITIS
STEVE, polymyositis In late april of 1997 I was diagnosed with polymyositis.My CPK level was 7,956. It all started in mid to late
http://www.rheumatic.org/steve.htm

Extractions: STEVE, polymyositis In late april of 1997 I was diagnosed with polymyositis. My CPK level was 7,956. It all started in mid to late january 97 with a pain in the calf of my right leg; then aches and pains with burning muscles that got progressively worse with each passing week. Swallowing became very difficult. It was like I had the worst case of the flu ever, multiplied by a thousand. Finally I went to my GP doctor. I was tested for hepatitis, liver disease, weeks of those tests with nothing confirmed. Then I saw his associate in his absence and she wanted me to have a special test (CPK). Meanwhile a friend of mine had a bad bacterial infection that was going around and she had taken Zithromax (azithromycin) to get rid of it. I thought that was probably what I had and was sure it would help me, because my symptons were the same, only more severe. So I made a deal with the doctor - I'd go immediately for the CPK test if she would give me a prescription for Zithromax. She agreed to do that, then stated it wouldn't help. That's when I had a CPK count of 7,956. But the Zithromax did help me quite a bit. The next day I was able to lift my arms, etc.
POLYMYOSITIS
LIANNE, polymyositis My life is my own once again! Two years agoI was diagnosed with polymyositis. I was devastated. I was a
http://www.rheumatic.org/lianne.htm

Extractions: LIANNE, polymyositis My life is my own once again! Two years ago I was diagnosed with polymyositis. I was devastated. I was a business owner, single parent, and a professional skater. I was so very tired, in a lot of pain, and, most of all, I feared for my life. Prior to being diagnosed I went from doctor to doctor trying to figure out what was wrong with me. I thought I was having an allergic reaction. I went to a third allergist. She interrogated me for over an hour. She ran a series of blood tests and discovered I had an elevated CPK. She confronted me assuming I was a cocaine addict and felt that must be the cause of my problem. I explained I didn't do drugs, but by the sound of the alternatives I almost wished that was the problem. I was sent to a rheumatologist. My diagnosis was confirmed by a muscle biopsy and an EMG. In that same breath that was used to give me the diagnosis, I was told that I had to have an AIDS test. I freaked. She failed to explain that the drugs she was going to prescribe were going to suppress my immune system and if I had AIDS, it would speed up my death. A psychiatrist had read to me all about being a hypochondriac, and I was told I was the healthiest looking sick person she had ever seen. When I told her how scared I was waiting for the AIDS test results, she told me, "You don't have AIDS. You had better hope you don't have polymyositis - you can die from that."

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

21-40 of 98 Back | 1 | 2 | 3 | 4 | 5 | Next 20